OPS
SUPN icon

Orion Portfolio Solutions’s Supernus Pharmaceuticals SUPN Stock Holding History

Orion Portfolio Solutions’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$418K Buy
+12,776
New +$453K ﹤0.01% 1490
2020
Q2 		– Sell
-152
Closed -$3K – 2451
2020
Q1 		$3K Buy
+152
New +$3.19K ﹤0.01% 1495

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Orion Portfolio Solutions's SUPN Position: Q1 2025 in Review

Orion Portfolio Solutions opened a new position in Supernus Pharmaceuticals (SUPN) in Q1 2025: 12,776 shares worth $418K. The stake represents ﹤0.01% of the portfolio and ranks #1490 among its holdings. This is a return to the name: Orion Portfolio Solutions previously reported a position in SUPN as recently as Q1 2020.

Orion Portfolio Solutions first reported a position in SUPN in Q1 2020 and has held it in 2 quarters since. 295 funds tracked by Wall St. Rank hold SUPN as of Q1 2025.

  • Orion Portfolio Solutions held 12,776 shares of Supernus Pharmaceuticals worth $418K as of Q1 2025.
  • Supernus Pharmaceuticals was a new Orion Portfolio Solutions position in Q1 2025.
  • Supernus Pharmaceuticals made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1490 holding.
  • Orion Portfolio Solutions first reported a position in Supernus Pharmaceuticals in Q1 2020 and has held it in 2 quarters since.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.